Cosmo Pharmaceuticals N.V. (FRA:C43)
51.00
-0.50 (-0.97%)
At close: May 7, 2025, 10:00 PM CET
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Own Products | 52.97M |
Log In |
Log In |
Log In |
Log In |
Own Products Growth | -0.64% |
Log In |
Log In |
Log In |
Log In |
Generic Products, Specialty Drugs and Related Services | 14.58M |
Log In |
Log In |
Log In |
Log In |
Generic Products, Specialty Drugs and Related Services Growth | 10.49% |
Log In |
Log In |
Log In |
Log In |
Royalties | 11.87M |
Log In |
Log In |
Log In |
Log In |
Royalties Growth | 19.90% |
Log In |
Log In |
Log In |
Log In |
Licence Fees, Up-front Fees and Milestones | 8.83M |
Log In |
Log In |
Log In |
Log In |
Licence Fees, Up-front Fees and Milestones Growth | -63.82% |
Log In |
Log In |
Log In |
Log In |
Other | 1.90M |
Log In |
Log In |
Log In |
Log In |
Other Growth | 13.68% |
Log In |
Log In |
Log In |
Log In |
MMX Products | - |
Log In |
Log In |
Log In |
Log In |
MMX Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Marketed Products - Eleview | - |
Log In |
Log In |
Log In |
Log In |
Marketed Products - Eleview Growth | - |
Log In |
Log In |
Log In |
Log In |
Related Services | - |
Log In |
Log In |
Log In |
Log In |
Related Services Growth | - |
Log In |
Log In |
Log In |
Log In |
GI Genius | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Italy | 90.14M |
Log In |
Log In |
Log In |
Log In |
Italy Growth | -12.03% |
Log In |
Log In |
Log In |
Log In |